찾기
프로덕트
커뮤니티
마켓
뉴스
브로커
더보기
KO
지금 시작
커뮤니티
/
아이디어
/
SRZN a Penny biotech LONG
Surrozen, Inc.
롱
SRZN a Penny biotech LONG
AwesomeAvani의
팔로우
팔로우
업데이트됨
2월 23일
1
환호
환호
2월 21일
SRZN has had good momentum. It has no revenues. Clinical trials but a lot of cash. SRZN has
advanced trials underway for a product to treat alcoholic hepatitis presumably settling it down
before it becomes irreversible cirrhosis (only for patients who are alcohol-free) and also useful
for liver metabolic disorders from a genetic basis.
SRZN has been trending up for a week with a bit of a pause in the middle of it. It picked up
60% of its price while breaking out through the anchored VWAP lines and the volume profile.
The far greater market is the former.
It is priced at 90 or more off it's all-time high of about $160. IF it picks up hype from the
last clinical trial getting a report and a calendared review by the, SRZN could reach for that
all time high. This is speculative and risky as are most biotechnology penny stocks. They are
trading news and potential not current net revenues. A small position with room in the stop
loss for the average range and volatility is best. This is a typical high risk higher potential
reward type of trade.
2월 21일
액티브 트레이드
One week chart was uploaded in error but does show the all-time high. Linked here
is the 15-minute version
2월 22일
액티브 트레이드
AI indicator suggests that price might be topping out later this morning. It has been
a good trade. looking to see if it reverses .
2월 23일
거래청산: 타겟 닿음
Reversal arrived and closed in profit.
biotechnology
biotechstocks
clinicalstudy
fdaapproval
LABU
Oscillators
pennystock
Volatility
Volume
XBI
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은
이용 약관
을 참고하세요.